By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Regeneron Pharmaceuticals, Inc. 

777 Old Saw Mill River Road

Tarrytown  New York  10591  U.S.A.
Phone: 914-847-7000 Fax: n/a


SEARCH JOBS



Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, allergic asthma, and atopic dermatitis.

Visit our website – www.regeneron.com
Check out our openings – http://careers.regeneron.com


Key Statistics


Email:
Ownership: Public

Web Site: Regeneron
Employees: 2300+
Symbol: REGN
 



Industry
Biotechnology


Collaborations

Sanofi US 

Bayer 

Geisinger Health System  Collaboration with Regeneron Genetics Center LLC, wholly-owned subsidiary of Regeneron.

Avalanche Biotech 





Company News
Teva (TEVA) Forges $2.6 Billion Deal to Buy Into Regeneron (REGN)'s Pain Drug Fasinumab 9/20/2016 5:47:48 AM
Only Behind Regeneron (REGN), EpiPen Maker Mylan (MYL) Execs are the Second Best Paid in the Industry 9/14/2016 7:55:26 AM
Regeneron (REGN) Announces Election Of Bonnie Bassler, Ph.D., And Huda Zoghbi, M.D., To Board Of Directors 9/12/2016 7:00:53 AM
Regeneron (REGN) Announces Upcoming 2016 Investor Conference Presentations 9/1/2016 12:58:26 PM
Regeneron (REGN), Sanofi (SNY)'s Potential Blockbuster Praluent Passes Late-Stage Test 8/29/2016 6:44:20 AM
Regeneron (REGN) Announces Agreement With BARDA For The Manufacturing And Testing Of New Antibodies Against MERS Virus 8/22/2016 6:52:40 AM
Regeneron (REGN) Reports Second Quarter 2016 Financial and Operating Results 8/4/2016 8:16:43 AM
After Bagging $51 Million in Early 2016, Bay Area's Adicet Bio Inks a Five-Year R&D Deal with Regeneron (REGN) 8/2/2016 6:55:20 AM
Sanofi (SNY) And Regeneron (REGN) Announce EMA Acceptance For Review Of Marketing Authorisation Application For Sarilumab 8/1/2016 8:55:03 AM
Regeneron (REGN) Announces Upcoming 2016 Investor Conference Presentation 7/18/2016 6:26:17 AM
12345678910...
//-->